Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.
Fumarate and nitrate reduction (FNR) dependent activation of the Escherichia coli anaerobic ribonucleotide reductase nrdDG promoter.
Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.
The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication.
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
Immune-driven recombination and loss of control after HIV superinfection.
HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.
Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance.
Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.